Plain-English translation of NCT04144907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is trying to solve a real problem: doctors don't have clear, evidence-based guidelines for how much protein patients with colorectal or breast cancer need during treatment. Muscle loss is common in cancer patients and linked to serious complications, longer hospital stays, and worse outcomes. This study will use a safe, non-invasive method to measure protein needs and help create better nutritional recommendations.
Many cancer patients lose dangerous amounts of muscle during treatment, which makes them weaker, increases infections and treatment side effects, and can shorten survival. Right now, doctors don't have solid scientific evidence about exactly how much protein these patients need to prevent this muscle loss and stay as healthy as possible.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic for baseline appointments within a few weeks of starting cancer treatment. During these visits, you'll provide urine, breath, and blood samples using a novel, non-invasive method to measure your protein needs. You may also need to eat specific meals provided by the study team as part of the testing process. The study aims to gather information that will help doctors create better protein guidelines for cancer patients like you.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Canada